Interim analyses, delivered cleanly
Blinded and unblinded interim analyses for active monitoring. Conditional and predictive power. Sample-size re-estimation within adaptive designs.
What we do
The interim-analysis portfolio
Blinded interim safety
Pre-specified blinded reviews to monitor safety without unblinding the sponsor.
Unblinded interim efficacy
Interim efficacy analyses for futility or success, driven by IDMC charter rules.
Conditional power & predictive power
Bayesian and frequentist computations to support DMC recommendations.
Sample-size re-estimation
SSR within group-sequential or adaptive designs.
DMC report packages
Closed-session statistical reports and open-session summaries.
Senior bench, active monitoring.
20+ PhD biostatisticians
120+ phase III studies
800+ studies overall
Adaptive and group-sequential expertise